Literature DB >> 24078486

Fluid responsiveness and brain tissue oxygen augmentation after subarachnoid hemorrhage.

Pedro Kurtz1, Raimund Helbok, Sang-Bae Ko, Jan Claassen, J Michael Schmidt, Luis Fernandez, R Morgan Stuart, E Sander Connolly, Neeraj Badjatia, Stephan A Mayer, Kiwon Lee.   

Abstract

BACKGROUND: The objective of this study was to investigate the relationship between cardiac index (CI) response to a fluid challenge and changes in brain tissue oxygen pressure (PbtO(2)) in patients with subarachnoid hemorrhage (SAH).
METHODS: Prospective observational study was conducted in a neurological intensive care unit of a university hospital. Fifty-seven fluid challenges were administered to ten consecutive comatose SAH patients that underwent multimodality monitoring of CI, intracranial pressure (ICP), and PbtO(2), according to a standardized fluid management protocol.
RESULTS: The relationship between CI and PbtO(2) was analyzed with logistic regression utilizing generalized estimating equations. Of the 57 fluid boluses analyzed, 27 (47 %) resulted in a ≥ 10 % increase in CI. Median absolute (+5.8 vs. +1.3 mmHg) and percent (20.7 vs. 3.5 %) changes in PbtO(2) were greater in CI responders than in non-responders within 30 min after the end of the fluid bolus infusion. In a multivariable model, a CI response was independently associated with PbtO(2) response (adjusted odds ratio 21.5, 95 % CI 1.4-324, P = 0.03) after adjusting for mean arterial pressure change and end-tidal CO(2). Stroke volume variation showed a good ability to predict CI and PbtO(2) response with areas under the ROC curve of 0.86 and 0.81 with the best cut-off values of 9 % for both responses.
CONCLUSION: Bolus fluid resuscitation resulting in augmentation of CI can improve cerebral oxygenation after SAH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24078486     DOI: 10.1007/s12028-013-9910-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  52 in total

Review 1.  Continuous monitoring of the microcirculation in neurocritical care: an update on brain tissue oxygenation.

Authors:  Jack C Rose; Terry A Neill; J Claude Hemphill
Journal:  Curr Opin Crit Care       Date:  2006-04       Impact factor: 3.687

2.  Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Sang-Bae Ko; Raimund Helbok; Pedro Kurtz; R Morgan Stuart; Mary Presciutti; Luis Fernandez; Kiwon Lee; Neeraj Badjatia; E Sander Connolly; Jan Claassen; Stephan A Mayer
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

3.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

4.  Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage.

Authors:  Sarah C Jost; Michael N Diringer; Allyson R Zazulia; Tom O Videen; Venkatesh Aiyagari; Robert L Grubb; William J Powers
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

5.  Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage.

Authors:  Rajat Dhar; Michael T Scalfani; Allyson R Zazulia; Tom O Videen; Colin P Derdeyn; Michael N Diringer
Journal:  J Neurosurg       Date:  2011-11-18       Impact factor: 5.115

6.  Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage.

Authors:  Tatsushi Mutoh; Ken Kazumata; Minoru Ajiki; Satoshi Ushikoshi; Shunsuke Terasaka
Journal:  Stroke       Date:  2007-11-08       Impact factor: 7.914

7.  Validation of a new arterial pulse contour-based cardiac output device.

Authors:  Eric E C de Waal; Cor J Kalkman; Steffen Rex; Wolfgang F Buhre
Journal:  Crit Care Med       Date:  2007-08       Impact factor: 7.598

8.  Impact of medical complications on outcome after subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

Review 9.  Cerebral vasospasm after subarachnoid hemorrhage.

Authors:  Nazli Janjua; Stephan A Mayer
Journal:  Curr Opin Crit Care       Date:  2003-04       Impact factor: 3.687

10.  A positive fluid balance is associated with a worse outcome in patients with acute renal failure.

Authors:  Didier Payen; Anne Cornélie de Pont; Yasser Sakr; Claudia Spies; Konrad Reinhart; Jean Louis Vincent
Journal:  Crit Care       Date:  2008-06-04       Impact factor: 9.097

View more
  10 in total

1.  What Do We Mean by Poor-Grade Aneurysmal Subarachnoid Hemorrhage and What Can We Do?

Authors:  Julian Bösel
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

2.  Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Takashi Tagami; Kentaro Kuwamoto; Akihiro Watanabe; Kyoko Unemoto; Shoji Yokobori; Gaku Matsumoto; Yutaka Igarashi; Hiroyuki Yokota
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 3.  Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations.

Authors:  Mauro Oddo; Daniele Poole; Raimund Helbok; Geert Meyfroidt; Nino Stocchetti; Pierre Bouzat; Maurizio Cecconi; Thomas Geeraerts; Ignacio Martin-Loeches; Hervé Quintard; Fabio Silvio Taccone; Romergryko G Geocadin; Claude Hemphill; Carole Ichai; David Menon; Jean-François Payen; Anders Perner; Martin Smith; José Suarez; Walter Videtta; Elisa R Zanier; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2018-03-02       Impact factor: 17.440

Review 4.  Postoperative ICU management of patients after subarachnoid hemorrhage.

Authors:  Shaun E Gruenbaum; Fedrico Bilotta
Journal:  Curr Opin Anaesthesiol       Date:  2014-10       Impact factor: 2.706

Review 5.  Fluid management of the neurological patient: a concise review.

Authors:  Mathieu van der Jagt
Journal:  Crit Care       Date:  2016-05-31       Impact factor: 9.097

Review 6.  Management of delayed cerebral ischemia after subarachnoid hemorrhage.

Authors:  Charles L Francoeur; Stephan A Mayer
Journal:  Crit Care       Date:  2016-10-14       Impact factor: 9.097

7.  The effect of the volemic and cardiac status on brain oxygenation in patients with subarachnoid hemorrhage: a bi-center cohort study.

Authors:  Verena Rass; Elisa Gouvea Bogossian; Bogdan-Andrei Ianosi; Lorenzo Peluso; Mario Kofler; Anna Lindner; Alois J Schiefecker; Lauma Putnina; Max Gaasch; Werner O Hackl; Ronny Beer; Bettina Pfausler; Fabio Silvio Taccone; Raimund Helbok
Journal:  Ann Intensive Care       Date:  2021-12-16       Impact factor: 6.925

8.  Development and validation of an early predictive nomogram for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Long Zhao; Tao Chen; Hao-Ji Yan; Chang Liu; Yi Cao; Yi Zhang; Ping Lin; Xiao-Ping Tang; Liang-Xue Zhou
Journal:  Ann Transl Med       Date:  2021-11

9.  Effect of inotropic agents on oxygenation and cerebral perfusion in acute brain injury.

Authors:  Giacomo Coppalini; Elie Duvigneaud; Alberto Diosdado; Ernesto Migliorino; Sophie Schuind; Jacques Creteur; Fabio Silvio Taccone; Elisa Gouvêa Bogossian
Journal:  Front Neurol       Date:  2022-07-19       Impact factor: 4.086

Review 10.  Multimorbidity and Critical Care Neurosurgery: Minimizing Major Perioperative Cardiopulmonary Complications.

Authors:  Rami Algahtani; Amedeo Merenda
Journal:  Neurocrit Care       Date:  2020-08-13       Impact factor: 3.210

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.